BTA
Click for more information
0.00% 57.0¢ biota holdings limited

possible manufacturing contract in india for relen

  1. mozz
    53 Posts.
    clock Created with Sketch.
    10/12/05
    17:51
    Post #: 1271554
    If this report is correct then GSK are in talks to expand production of Relenza with Nicholas Piramal India . One would expect that this means they have commitments for the medication .

    I am a holder of BTA

    http://www.expresspharmapulse.com/20051215/market08.shtml
    BTA Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.